Skip to main content
logo
Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India flag India · Delayed Price · Currency is INR
913.65
-4.45 (-0.48%)
At close: Dec 18, 2025

Zydus Lifesciences Revenue

Zydus Lifesciences had revenue of 61.23B INR in the quarter ending September 30, 2025, with 16.92% growth. This brings the company's revenue in the last twelve months to 244.94B, up 14.01% year-over-year. In the fiscal year ending March 31, 2025, Zydus Lifesciences had annual revenue of 232.42B with 18.90% growth.

Revenue (ttm)
244.94B
Revenue Growth
+14.01%
P/S Ratio
3.75
Revenue / Employee
8.77M
Employees
27,917
Market Cap
919.35B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025232.42B36.94B18.90%
Mar 31, 2024195.47B23.10B13.40%
Mar 31, 2023172.37B21.28B14.08%
Mar 31, 2022151.10B7.06B4.90%
Mar 31, 2021144.04B1.50B1.06%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sun Pharmaceutical Industries549.64B
Aurobindo Pharma325.14B
Cipla279.66B
Apollo Hospitals Enterprise232.65B
Biocon164.76B
Glenmark Pharmaceuticals159.97B
Alkem Laboratories138.90B
Mankind Pharma135.46B
Revenue Rankings

Zydus Lifesciences News

More News